Aucta Pharmaceuticals focuses on core therapeutic areas characterized by high unmet clinical needs and strong commercial potential:

(1) Central Nervous System (CNS) Disorders,

(2) Orphan and Specialty Indications.

These areas share common challenges — unmet clinical needs, long-term treatment requirements, adherence difficulties, and limited patient-friendly dosage forms — which Aucta addresses through its proprietary controlled-release, nasal delivery, and pediatric formulation platforms.